Search - tctmd.com

Displaying 1 - 20 of 103

Sort: Relevancy | Date

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

May 09, 2025

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

May 06, 2025

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

News Daily News

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

September 26, 2024

Statins Are Cost-effective in the Elderly

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

Acute HF Patients Live Longer When Seen by Specialists

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

ACC/AHA Update Performance, Quality Measures for HF Care

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

August 08, 2024

Obstacles Abound for Treating Severe BP: Some Clues for Care Lie in EHRs

News Daily News

Obstacles Abound for Treating Severe BP: Some Clues for Care Lie in EHRs

August 08, 2024

Mechanism’s Mojo ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

DOAC Don’ts New Review Clarifies When Not to Use Direct Oral Anticoagulants

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

January 17, 2024

Experts Warn of Looming Private Equity Interest in Cardiology Care

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

Lipid Panels in Standard Precath Blood Draws? Researchers Say It’s Time

News Daily News

Lipid Panels in Standard Precath Blood Draws? Researchers Say It’s Time

June 13, 2023

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

News Daily News

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

March 31, 2023

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

News Daily News

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

Michael O'Riordan

March 01, 2023

Only Half of Revascularized PAD Patients Receive GDMT

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

February 14, 2023

RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads

News Daily News

RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads

January 19, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.